Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1985 Mar;53(3):976–979. doi: 10.1128/jvi.53.3.976-979.1985

Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection.

R Vainionpää, O Meurman, H Sarkkinen
PMCID: PMC254736  PMID: 3973971

Abstract

The purified respiratory syncytial virus (RSV), Randall strain contained 10 polypeptides (72,000 molecular weight [72K], 66K, 48K, 42K, 40K, 36K, 30K, 23K, 18K, and 15K), 8 of which proved to be virus specific, and polypeptides 48K and 23K were glycosylated. In addition, a high-molecular-weight (150K), virus-specific glycopolypeptide was immunoprecipitated from RSV-infected cell lysate. The antibody response in human sera serially collected from children with primary RSV infection was mainly directed against the polypeptides 30K, 48K, and 72K. The immune response against the other viral proteins was also already detectable in the acute-phase sera. These results indicate that the immune response in RSV infection differs significantly from those for other diseases caused by paramyxoviruses.

Full text

PDF
976

Images in this article

977Image
on p.977
978Image
on p.978

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belshe R. B., Van Voris L. P., Mufson M. A. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J Infect Dis. 1982 Mar;145(3):311–319. doi: 10.1093/infdis/145.3.311. [DOI] [PubMed] [Google Scholar]
  2. Bernstein J. M., Hruska J. F. Respiratory syncytial virus proteins: identification by immunoprecipitation. J Virol. 1981 Apr;38(1):278–285. doi: 10.1128/jvi.38.1.278-285.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cash P., Wunner W. H., Pringle C. R. A comparison of the polypeptides of human and bovine respiratory syncytial viruses and murine pneumonia virus. Virology. 1977 Oct 15;82(2):369–379. doi: 10.1016/0042-6822(77)90012-5. [DOI] [PubMed] [Google Scholar]
  4. Chamberlain J. P. Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate. Anal Biochem. 1979 Sep 15;98(1):132–135. doi: 10.1016/0003-2697(79)90716-4. [DOI] [PubMed] [Google Scholar]
  5. Dubovi E. J. Analysis of proteins synthesized in respiratory syncytial virus-infected cells. J Virol. 1982 May;42(2):372–378. doi: 10.1128/jvi.42.2.372-378.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fernie B. F., Cote P. J., Jr, Gerin J. L. Classification of hybridomas to respiratory syncytial virus glycoproteins. Proc Soc Exp Biol Med. 1982 Dec;171(3):266–271. doi: 10.3181/00379727-171-41509. [DOI] [PubMed] [Google Scholar]
  7. Fernie B. F., Gerin J. L. Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion. Infect Immun. 1982 Jul;37(1):243–249. doi: 10.1128/iai.37.1.243-249.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Graves M., Griffin D. E., Johnson R. T., Hirsch R. L., de Soriano I. L., Roedenbeck S., Vaisberg A. Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections. J Virol. 1984 Feb;49(2):409–412. doi: 10.1128/jvi.49.2.409-412.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969 Apr;89(4):422–434. doi: 10.1093/oxfordjournals.aje.a120955. [DOI] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Machamer C. E., Hayes E. C., Gollobin S. D., Westfall L. K., Zweerink H. J. Antibodies against the measles matrix polypeptide after clinical infection and vaccination. Infect Immun. 1980 Mar;27(3):817–825. doi: 10.1128/iai.27.3.817-825.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Merz D. C., Scheid A., Choppin P. W. Immunological studies of the functions of paramyxovirus glycoproteins. Virology. 1981 Feb;109(1):94–105. doi: 10.1016/0042-6822(81)90474-8. [DOI] [PubMed] [Google Scholar]
  13. Meurman O., Ruuskanen O., Sarkkinen H., Hänninen P., Halonen P. Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay. J Med Virol. 1984;14(1):67–72. doi: 10.1002/jmv.1890140110. [DOI] [PubMed] [Google Scholar]
  14. Montelaro R. C., Rueckert R. R. Radiolabeling of proteins and viruses in vitro by acetylation with radioactive acetic anhydride. J Biol Chem. 1975 Feb 25;250(4):1413–1421. [PubMed] [Google Scholar]
  15. Norrby E., Orvell C., Vandvik B., Cherry J. D. Antibodies against measles virus polypeptides in different disease conditions. Infect Immun. 1981 Dec;34(3):718–724. doi: 10.1128/iai.34.3.718-724.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Peeples M., Levine S. Respiratory syncytial virus polypeptides: their location in the virion. Virology. 1979 May;95(1):137–145. doi: 10.1016/0042-6822(79)90408-2. [DOI] [PubMed] [Google Scholar]
  17. Sarkkinen H. K., Halonen P. E., Arstila P. P., Salmi A. A. Detection of respiratory syncytial, parainfluenza type 2, and adenovirus antigens by radioimmunoassay and enzyme immunoassay on nasopharyngeal specimens from children with acute respiratory disease. J Clin Microbiol. 1981 Feb;13(2):258–265. doi: 10.1128/jcm.13.2.258-265.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vainionpä R., Joronen I., Hyypiä T. The measles virus-specific protein synthesis of persistently and lytically infected cells studied in vivo and in vitro. Acta Pathol Microbiol Scand B. 1981 Dec;89(6):371–378. doi: 10.1111/j.1699-0463.1981.tb00203_89b.x. [DOI] [PubMed] [Google Scholar]
  19. Vainiopä R., Ziola B., Salmi A. Measles virus polypeptides in purified virions and in infected cells. Acta Pathol Microbiol Scand B. 1978 Dec;86B(6):379–385. doi: 10.1111/j.1699-0463.1978.tb00060.x. [DOI] [PubMed] [Google Scholar]
  20. Walsh E. E., Hruska J. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J Virol. 1983 Jul;47(1):171–177. doi: 10.1128/jvi.47.1.171-177.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Walsh E. E., Schlesinger J. J., Brandriss M. W. Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. J Gen Virol. 1984 Apr;65(Pt 4):761–767. doi: 10.1099/0022-1317-65-4-761. [DOI] [PubMed] [Google Scholar]
  22. Ward K. A., Lambden P. R., Ogilvie M. M., Watt P. J. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. J Gen Virol. 1983 Sep;64(Pt 9):1867–1876. doi: 10.1099/0022-1317-64-9-1867. [DOI] [PubMed] [Google Scholar]
  23. Wunner W. H., Pringle C. R. Respiratory syncytial virus proteins. Virology. 1976 Aug;73(1):228–243. doi: 10.1016/0042-6822(76)90077-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES